BOSWORTH MEDICAL GROUP — All Prescriptions & Medications — Page 3
Practice Code: M89008 | BIRMINGHAM, B37 5BU
Showing results 101-150 of 686
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Thiamine hydrochloride | 659 | 43.5K | £1.1K | +25.0% ▲ |
| Mebeverine hydrochloride | 643 | 52.4K | £1.8K | +107.1% ▲ |
| 642 | 680 | £4.2K | +171.8% ▲ | |
| Sumatriptan succinate | 636 | 4,610 | £1.9K | +79.6% ▲ |
| Lactulose | 630 | 371.8K | £3.5K | +91.4% ▲ |
| Rivaroxaban | 621 | 18.8K | £14.8K | +1.5% vs avg |
| Linagliptin | 619 | 17.7K | £20.0K | +51.1% ▲ |
| Loperamide hydrochloride | 612 | 46.4K | £2.3K | +162.8% ▲ |
| Sodium valproate | 611 | 84.9K | £12.5K | +92.1% ▲ |
| 582 | 110.4K | £6.4K | +473.0% ▲ | |
| Zopiclone | 578 | 9,586 | £409 | +4.4% ▲ |
| Quinine sulfate | 577 | 16.6K | £2.7K | +99.3% ▲ |
| Budesonide | 575 | 1,219 | £18.4K | +6.1% ▲ |
| Olanzapine | 563 | 16.7K | £2.3K | +52.0% ▲ |
| 561 | 1,149 | £39.2K | +2.9% ▲ | |
| Estradiol with progestogen | 559 | 24.3K | £14.5K | +64.0% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 557 | 560 | £24.6K | +233.0% ▲ |
| Clarithromycin | 556 | 12.0K | £2.5K | +126.6% ▲ |
| Carbamazepine | 554 | 58.5K | £3.1K | +86.7% ▲ |
| Diltiazem hydrochloride | 553 | 25.8K | £4.1K | +80.1% ▲ |
| 550 | 277.6K | £3.4K | +108.5% ▲ | |
| Perindopril erbumine | 549 | 17.3K | £1.2K | +3.4% ▲ |
| Lidocaine hydrochloride | 545 | 1,346 | £1.4K | +215.9% ▲ |
| Hyoscine butylbromide | 540 | 56.0K | £3.9K | +131.7% ▲ |
| Fluticasone furoate/vilanterol | 532 | 535 | £12.7K | +243.6% ▲ |
| Mometasone furoate | 526 | 543 | £4.2K | +31.0% ▲ |
| Aripiprazole | 505 | 16.7K | £2.4K | +98.5% ▲ |
| Sacubitril/valsartan | 501 | 27.9K | £45.6K | +109.2% ▲ |
| Pravastatin sodium | 500 | 15.0K | £714 | +54.0% ▲ |
| Famotidine | 495 | 16.1K | £9.2K | +1.4% vs avg |
| Methylprednisolone acetate | 493 | 537 | £1.7K | +327.0% ▲ |
| Mirabegron | 492 | 14.7K | £13.5K | +22.5% ▲ |
| Buprenorphine | 478 | 1,678 | £8.3K | +30.5% ▲ |
| Trimethoprim | 473 | 18.3K | £881 | +131.5% ▲ |
| Enalapril maleate | 447 | 15.3K | £950 | +148.8% ▲ |
| Hydroxocobalamin | 445 | 1,146 | £2.4K | -7.5% ▼ |
| Irbesartan | 438 | 14.3K | £555 | +79.8% ▲ |
| Biphasic insulin aspart | 420 | 3,492 | £20.8K | +313.6% ▲ |
| Hypromellose | 420 | 4,340 | £781 | +217.0% ▲ |
| Mesalazine (Systemic) | 410 | 39.5K | £21.6K | +71.2% ▲ |
| Ferrous fumarate | 408 | 28.1K | £985 | -43.7% ▼ |
| Nifedipine | 403 | 25.6K | £6.3K | +115.0% ▲ |
| Calcipotriol | 400 | 33.0K | £18.9K | +135.0% ▲ |
| Oxybutynin | 397 | 21.4K | £2.7K | +108.4% ▲ |
| Risperidone | 387 | 19.3K | £2.8K | +53.0% ▲ |
| Beclometasone dipropionate | 387 | 397 | £1.1K | +79.9% ▲ |
| Medroxyprogesterone acetate | 373 | 373 | £2.1K | +208.9% ▲ |
| Progesterone | 362 | 19.7K | £3.9K | -13.5% ▼ |
| Combined ethinylestradiol 30mcg | 358 | 33.1K | £2.0K | +28.9% ▲ |
| Cyanocobalamin | 356 | 16.2K | £1.4K | +0.8% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.